Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

BioLine RX Ltd ADR buy nvestor

BioLine RX Ltd ADR
Start price
€2.14
09.09.23 / 50%
Target price
€3.00
09.09.24
Performance (%)
-18.69%
End price
€1.74
16.09.23
Summary
This prediction ended on 16.09.23 with a price of €1.74. The price of BioLine RX Ltd ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -18.69%. nvestor has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
BioLine RX Ltd ADR 7.563% 7.563%
iShares Core DAX® 2.831% 1.236%
iShares Nasdaq 100 2.918% 0.640%
iShares Nikkei 225® 2.007% -2.135%
iShares S&P 500 2.257% 0.451%

According to nvestor what are the pros and cons of BioLine RX Ltd ADR for the foreseeable future?

Pros
Cons
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
negative Cash Flow expected
Bad rating
Little Investments for future growth
Risky balance sheet
Below average Management
Growths slower than the competition
Sustainability is little important
high free float
Higher risks for its business
Below average Marketposition
Business model of the past or high risk
Lower EBIT Margin than peer group
Increased challenges to pay loans and raise capital
Bad culture
Little innovation
Few uniques
Significant cyclical dependencies
Little known brand
Low dividend yield expected
ROE lower than 10% per year
Dependend from some customers or products

Comments by nvestor for this prediction

In the thread BioLine RX Ltd ADR diskutieren
Prediction Buy
Perf. (%) -18.69%
Target price 3.000
Change
Ends at

Buy mit Kursziel 3,0

nvestor 
0
Report Share
09.09.23
In the thread Trading BioLine RX Ltd ADR
Prediction Buy
Perf. (%) -18.69%
Target price 3.000
Change
Ends at 09.09.24

Einschätzung wurde nach dem Ende von Catch the Monkey automatisch beendet.

nvestor 
0
Report Share
16.09.23

Stopped prediction by nvestor for BioLine RX Ltd ADR

sell
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.64
30.09.23
€1.00
30.09.24
-9.76%
14.10.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
nvestor 
30.09.23 50%
sell
BioLine RX Ltd ADR

Start price
Target price
Perf. (%)
€1.77
31.10.20
€0.000
04.11.21
4.52%
14.11.20

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
nvestor 
31.10.20 50%